Skip to NavigationSkip to content

Pharmafile - Medical Communications

Japan approves Gilead and Eisai's Jyseleca for rheumatoid arthritis
The approval relates to patients for whom conventional therapies for the prevention of structural joint damage have not been effective.
GSK confirms deal to supply 300 million COVID-19 vaccine doses to the EU
Under the terms of the agreement, the EU will also have the option to provide a proportion of the reserved doses to low and middle-income nations.
Trump approves plan to make the import of Canadian drugs easier
President Trump has outlined his “America First Health Plan” on Thursday, which will allow the easy importation of prescription drugs from Canada.
British consumers have increasingly turned to community pharmacies during COVID-19
British consumers have increasingly turned to community pharmacies during the coronavirus pandemic, according to a new study.
>> More Medical Communications News Stories

Features

Oncology research in the age of COVID-19

Matt Fellows investigates the new challenges facing the oncology space and explores the strategies that can carry it through the disruptive...

>> More Features

Appointments

Targazyme snaps up new CEO

Experienced industry executive James Caggiano has been named as the new head of Californian biotech Targazyme, who will take up the mantle of the...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches